Professor Peter Stonebridge

Professor Stonebridge is a consultant Vascular Surgeon, working entirely in the field of vascular disease. After qualifying from Manchester Medical School his training in Vascular Surgery was undertaken in Manchester and Edinburgh with a period as a Vascular Research Fellow at Harvard Medical School, Boston. He has published extensively in the field of Vascular Disease and Vascular Surgery.

He is responsible for basic and clinical scientific research in the Spiral Laminar Flow™ field.

Professor Graeme Houston

Dr Houston is a consultant Vascular Radiologist with an interest in endo-vascular therapies, and non-invasive vascular imaging using MRI and Ultrasound. His medical training at St. Thomas's Hospital in London followed first class honours science degrees in physics and pathology at Cambridge University. His endo-vascular training was undertaken initially in Glasgow and further developed as Fellow in University of British Columbia, Vancouver, Canada.

He is responsible for intellectual property, and as Medical Director is responsible for the clinical scientific research in the Spiral Laminar Flow™ field and stent technology.

Doctor John Dick

Dr Dick graduated from Edinburgh Medical School and trained as a Registrar in General Medicine, Renal and Transplant Medicine, and in Chemical Pathology, in Edinburgh and latterly in Dundee. He is currently a Consultant in the vascular team at Ninewells Hospital in Dundee . In this post he researches atherosclerosis and runs the Ninewells Lipid Clinic as well as his general duties.

He is responsible for the clinical scientific research in the Spiral Laminar Flow™ field.

David Lawrence - Chief Executive Officer

David is ex-CFO of Acambis plc and has previously worked at Chiron (now part of Novartis) and GlaxoSmithKline. David has 20 years of experience in the Lifesciences industry and has a strong track record of business development including M&A and licensing. David has extensive international experience and has held a variety of operational and finance roles in his career. He has experience of working with investors and brings strong general management experience to the company. David joined the company in September 2007.